The Role of HMGB1 Signaling Pathway in the Development and Progression of Hepatocellular Carcinoma: A Review
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of HMGB1 Signaling Pathway in the Development and Progression of Hepatocellular Carcinoma: A Review
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 16, Issue 9, Pages 22527-22540
Publisher
MDPI AG
Online
2015-09-18
DOI
10.3390/ijms160922527
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Expression of the Inflammatory Molecule HMGB1 in Human Osteosarcoma and its Clinical Relevance
- (2017) B. Li et al. European Journal of Inflammation
- Enhancing the Therapeutic Effects of Ethyl Pyruvate on Gastric Cancer through Knockdown of YAP1 Expression
- (2017) J. Zhang et al. European Journal of Inflammation
- Comment on: HMGB1-dependent and -independent autophagy
- (2015) Peter Huebener et al. Autophagy
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Epidemiological-molecular evidence of metabolic reprogramming on proliferation, autophagy and cell signaling in pancreas cancer
- (2015) Kjetil Søreide et al. CANCER LETTERS
- High-Mobility Group Box 1 Promotes Hepatocellular Carcinoma Progression through miR-21-Mediated Matrix Metalloproteinase Activity
- (2015) M. Chen et al. CANCER RESEARCH
- Hypoxia induced HMGB1 and mitochondrial DNA interactions mediate tumor growth in hepatocellular carcinoma through Toll-like receptor 9
- (2015) Yao Liu et al. JOURNAL OF HEPATOLOGY
- Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat–cholesterol–sugar diet model in mice
- (2015) Michal Ganz et al. Journal of Translational Medicine
- High-mobility group box 1 has a prognostic role and contributes to epithelial mesenchymal transition in human hepatocellular carcinoma
- (2015) ZHIKUI LIU et al. Molecular Medicine Reports
- High Mobility Group Box 1 Protein Is Methylated and Transported to Cytoplasm in Clear Cell Renal Cell Carcinoma
- (2014) Fei Wu et al. Asian Pacific Journal of Cancer Prevention
- HMGB1-dependent and -independent autophagy
- (2014) Xiaofang Sun et al. Autophagy
- Extracellular HMGB1 promotes differentiation of nurse-like cells in chronic lymphocytic leukemia
- (2014) L. Jia et al. BLOOD
- High-Mobility Group Box 1 Is Dispensable for Autophagy, Mitochondrial Quality Control, and Organ Function In Vivo
- (2014) Peter Huebener et al. Cell Metabolism
- Association of Upregulated HMGB1 and c-IAP2 Proteins With Hepatocellular Carcinoma Development and Progression
- (2014) Man Ru Bi et al. Hepatitis Monthly
- Expression and Effects of High-Mobility Group Box 1 in Cervical Cancer
- (2014) Xiaoao Pang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Knockdown of HMGB1 inhibits growth and invasion of gastric cancer cells through the NF-κB pathway in vitro and in vivo
- (2014) JING ZHANG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis
- (2014) Peter Huebener et al. JOURNAL OF CLINICAL INVESTIGATION
- Role of high mobility group box 1 and its signaling pathways in renal diseases
- (2014) Tian-Biao Zhou JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION
- The role of HMGB1-RAGE axis in migration and invasion of hepatocellular carcinoma cell lines
- (2014) Ruo-Chan Chen et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- HMGB1 in health and disease
- (2014) Rui Kang et al. MOLECULAR ASPECTS OF MEDICINE
- The Association of HMGB1 Gene with the Prognosis of HCC
- (2014) Jianbiao Xiao et al. PLoS One
- Suppression of toll-like receptor 2 expression inhibits the bioactivity of human hepatocellular carcinoma
- (2014) Wenna Shi et al. TUMOR BIOLOGY
- Platelets promote tumour metastasis via interaction between TLR4 and tumour cell-released high-mobility group box1 protein
- (2014) Le-Xing Yu et al. Nature Communications
- HMGB1 is involved in autophagy inhibition caused by SNCA/α-synuclein overexpression
- (2013) Ju-Xian Song et al. Autophagy
- Ethyl pyruvate inhibits proliferation and induces apoptosis of hepatocellular carcinoma via regulation of the HMGB1–RAGE and AKT pathways
- (2013) Ping Cheng et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Crosstalk between apoptosis, necrosis and autophagy
- (2013) Vassiliki Nikoletopoulou et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- HMGB1 in Cancer: Good, Bad, or Both?
- (2013) R. Kang et al. CLINICAL CANCER RESEARCH
- The noninflammatory role of high mobility group box 1/toll-like receptor 2 axis in the self-renewal of mammary cancer stem cells
- (2013) Laura Conti et al. FASEB JOURNAL
- Intracellular Hmgb1 Inhibits Inflammatory Nucleosome Release and Limits Acute Pancreatitis in Mice
- (2013) Rui Kang et al. GASTROENTEROLOGY
- Receptor for advanced glycation endproducts (RAGE) is a key regulator of oval cell activation and inflammation-associated liver carcinogenesis in mice
- (2013) Tobias Pusterla et al. HEPATOLOGY
- Hepatocyte-specific high-mobility group box 1 deletion worsens the injury in liver ischemia/reperfusion: A role for intracellular high-mobility group box 1 in cellular protection
- (2013) Hai Huang et al. HEPATOLOGY
- Circulating nucleosomes and immunogenic cell death markers HMGB1, sRAGE and DNAse in patients with advanced pancreatic cancer undergoing chemotherapy
- (2013) Christin Wittwer et al. INTERNATIONAL JOURNAL OF CANCER
- Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis
- (2013) Yoon Seok Roh et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- p53 promotes inflammation-associated hepatocarcinogenesis by inducing HMGB1 release
- (2013) He-Xin Yan et al. JOURNAL OF HEPATOLOGY
- The HMGB1/RAGE inflammatory pathway promotes pancreatic tumor growth by regulating mitochondrial bioenergetics
- (2013) R Kang et al. ONCOGENE
- Invasion potential of H22 hepatocarcinoma cells is increased by HMGB1-induced tumor NF-κB signaling via initiation of HSP70
- (2013) WEI GONG et al. ONCOLOGY REPORTS
- Conditional ablation of HMGB1 in mice reveals its protective function against endotoxemia and bacterial infection
- (2013) H. Yanai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anti-Inflammatory and Anti-Mutagenic Effect of the YHK Phytocompound in Hepatocytes: In View of an Age-Management Liver-Protecting Approach
- (2013) Roberto Catanzaro et al. REJUVENATION RESEARCH
- Expression of HMGB1 and NF-κB p65 and its significance in non-small cell lung cancer
- (2013) Xiaohong Zhang et al. Wspolczesna Onkologia-Contemporary Oncology
- Erratum: The novel BH-3 mimetic apogossypolone induces Beclin-1- and ROS-mediated autophagy in human hepatocellular carcinoma cells
- (2013) P Cheng et al. Cell Death & Disease
- HMGB1 was a pivotal synergistic effecor for CpG oligonucleotide to enhance the progression of human lung cancer cells
- (2012) Chunhong Wang et al. CANCER BIOLOGY & THERAPY
- The Proinflammatory Myeloid Cell Receptor TREM-1 Controls Kupffer Cell Activation and Development of Hepatocellular Carcinoma
- (2012) Juan Wu et al. CANCER RESEARCH
- High-mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases
- (2012) Wei Yan et al. HEPATOLOGY
- The Role of Receptor for Advanced Glycation End Products (RAGE) in the Proliferation of Hepatocellular Carcinoma
- (2012) Al-Madhagi Yaser et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Profound impact of gut homeostasis on chemically-induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats
- (2012) Hui-Lu Zhang et al. JOURNAL OF HEPATOLOGY
- Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1
- (2012) Shigeki Chiba et al. NATURE IMMUNOLOGY
- Expression and clinical significance of HMGB1 in human liver cancer: Knockdown inhibits tumor growth and metastasis in vitro and in vivo
- (2012) YA-DONG DONG et al. ONCOLOGY REPORTS
- Potentiation of NMDA Receptor-Dependent Cell Responses by Extracellular High Mobility Group Box 1 Protein
- (2012) Marco Pedrazzi et al. PLoS One
- Predictive value of immunogenic cell death biomarkers HMGB1, sRAGE, and DNase in liver cancer patients receiving transarterial chemoembolization therapy
- (2012) Nikolaus Kohles et al. TUMOR BIOLOGY
- Circulating immunogenic cell death biomarkers HMGB1 and RAGE in breast cancer patients during neoadjuvant chemotherapy
- (2012) Oliver J. Stoetzer et al. TUMOR BIOLOGY
- Glycer-AGEs-RAGE signaling enhances the angiogenic potential of hepatocellular carcinoma by upregulating VEGF expression
- (2012) Junichi Takino WORLD JOURNAL OF GASTROENTEROLOGY
- Glycyrrhizin attenuates HMGB1-induced hepatocyte apoptosis by inhibiting the p38-dependent mitochondrial pathway
- (2012) Geum-Youn Gwak WORLD JOURNAL OF GASTROENTEROLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Effect of HMGB1 silencing on cell proliferation, invasion and apoptosis of MGC-803 gastric cancer cells
- (2011) Bao Song et al. CELL BIOCHEMISTRY AND FUNCTION
- Tumor-Derived Autophagosome Vaccine: Mechanism of Cross-Presentation and Therapeutic Efficacy
- (2011) Y. Li et al. CLINICAL CANCER RESEARCH
- Reduced High-Mobility Group Box 1 Expression Induced by RNA Interference Inhibits the Bioactivity of Hepatocellular Carcinoma Cell Line HCCLM3
- (2011) Wei Jiang et al. DIGESTIVE DISEASES AND SCIENCES
- Heparan Sulfate Is Essential for High Mobility Group Protein 1 (HMGB1) Signaling by the Receptor for Advanced Glycation End Products (RAGE)
- (2011) Ding Xu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- HMGB1 inhibits macrophage activity in efferocytosis through binding to the αvβ3-integrin
- (2010) Arnaud Friggeri et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- TLR4-mediated skin carcinogenesis is dependent on immune and radioresistant cells
- (2010) Deepak Mittal et al. EMBO JOURNAL
- Inhibitor of NF- B Kinases and Are Both Essential for High Mobility Group Box 1-Mediated Chemotaxis
- (2010) M. Penzo et al. JOURNAL OF IMMUNOLOGY
- HMGB1 Attenuates Anti-Metastatic Defense of the Lymph Nodes in Colorectal Cancer
- (2010) Yukiko Moriwaka et al. PATHOBIOLOGY
- High-Mobility Group Box 1–Mediated Matrix Metalloproteinase-9 Expression in Non–Small Cell Lung Cancer Contributes to Tumor Cell Invasiveness
- (2009) Po-Len Liu et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer
- (2009) Hye Chung et al. Journal of Translational Medicine
- The expression of HMGB1 protein and its receptor RAGE in human malignant tumors
- (2009) Nora Kostova et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Serum high mobility group box protein 1 as a clinical marker for non-small cell lung cancer
- (2009) Guan-Hong Shang et al. RESPIRATORY MEDICINE
- CD24 and Siglec-10 Selectively Repress Tissue Damage-Induced Immune Responses
- (2009) G.-Y. Chen et al. SCIENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started